{"filing":{"accession_number":"0001683168-26-004540","cik":"0000882291","ticker":"AEMD","company_name":"AETHLON MEDICAL INC","form":"8-K","filing_date":"2026-06-04","report_date":null,"primary_document":"aethlon_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316826004540/aethlon_8k.htm"},"events":[{"id":6995,"run_id":6135,"accession_number":"0001683168-26-004540","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"The filing discloses an At Market Offering (ATM) agreement under which Aethlon Medical may offer and sell up to $542,716 of additional common stock pursuant to an amended prospectus supplement. This represents a dilutive equity issuance registered under Form S-3, with shares eligible for sale in the public market. The company had previously sold $1,849,457 of shares under the same ATM agreement, demonstrating active capital raising through equity dilution.","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-06-04","form":"8-K","submitted_at":null,"items":[{"id":4551,"accession_number":"0001683168-26-004540","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses an At Market Offering (ATM) agreement under which Aethlon Medical may offer and sell up to $542,716 of additional common stock pursuant to an amended prospectus supplement. This represents a dilutive equity issuance registered under Form S-3, with shares eligible for sale in the public market. The company had previously sold $1,849,457 of shares under the same ATM agreement, demonstrating active capital raising through equity dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:27:05.503147+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4551,"accession_number":"0001683168-26-004540","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses an At Market Offering (ATM) agreement under which Aethlon Medical may offer and sell up to $542,716 of additional common stock pursuant to an amended prospectus supplement. This represents a dilutive equity issuance registered under Form S-3, with shares eligible for sale in the public market. The company had previously sold $1,849,457 of shares under the same ATM agreement, demonstrating active capital raising through equity dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:27:05.503147+00:00","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-06-04"}]}